ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 163062 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 163062; 2) Community: the network communities that were significantly associated with the response to NSC 163062; 3) Molecule: the relationships between components within communities and NSC 163062; 4) MDR: the compounds that were significantly associated with the NSC 163062.

NSC Compound Enrichment Correlation
NSC 733504 Everolimus 0.0342636096654271 -0.12485051
NSC 736802 Null 0.0342636096654271 0.20304828
NSC 737231 Null 0.0342636096654271 0.26664329
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.0342636096654271 0.023182488
NSC 740 Methotrexate 0.0342636096654271 0.21589429
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.0342636096654271 0.12383052
NSC 747461 Null 0.0342636096654271 -0.075416659
NSC 753769 Null 0.0342636096654271 -0.071772005
NSC 758881 Orlistat (USAN) 0.0342636096654271 0.10486327
NSC 87222 ACTINOMYCIN C3 0.0342636096654271 0.33572742
Total:156  Current:125    [First] [Prev] [Next] [Last]